Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AliCsa: Oral alitretinoin versus oral cyclosporine in moderate to very severe hand eczema
2024-515140-23-00Phase 4Authorised
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2024
- Modality
- Small Molecules, Peptides, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in hand dermatitis comparing Oral alitretinoin with Oral cyclosporine (2 arms). Primary endpoint: Primary efficacy endpoint. Planned start Nov 2024; status: authorised.
02
Drugs
alitretinoincyclosporine
03
Conditions
hand dermatitis
Beyond the preview
Go deeper on 2024-515140-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515140-23-00.